JVA vs MED: stock comparison and AI forecast
Coffee Holding Co Inc (JVA) and Medifast Inc (MED) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
JVA Coffee Holding Co Inc
- Price
- $4.82 +13.1% · 6M
- Market Cap
- $28M
- P/E Ratio
- 6.0x
- Size
- small-cap
- AI Forecast
MED Medifast Inc
- Price
- $12.73 +0.3% · 6M
- Market Cap
- $142M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- MED is 5.2 times larger than JVA by market capitalization ($142M against $28M).
- Over the last six months JVA returned +13.1% and MED +0.3%.
- JVA turns 5.0% of its revenue into net income, against -13.6% for MED.
- MED carries 0.33 times debt per unit of equity, against 0.30 times for JVA.
- MED yields 0.51% in dividends; JVA pays none.
- Both companies share the SEC industry classification Miscellaneous Food Preparations & Kindred Products.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | JVA | MED |
|---|---|---|
| Market Cap | $28M | $142M |
| P/E Ratio | 5.95x | – |
| P/B Ratio | 0.89x | 0.79x |
| Dividend Yield | – | 0.51% |
| EPS | $0.81 | $-3.06 |
| Book Value/Share | $5.43 | $16.12 |
| Revenue/Share | $20.75 | $26.79 |
| FCF/Share | $1.40 | $-0.35 |
Profitability & Margins
| Metric | JVA | MED |
|---|---|---|
| ROE | 18.9% | -22.7% |
| ROA | 14.6% | -17.0% |
| ROIC | 23.1% | -17.6% |
| Gross Margin | 4.3% | 69.2% |
| Operating Margin | 6.2% | -11.6% |
| Net Margin | 5.0% | -13.6% |
| EBT Margin | 6.0% | -9.7% |
| Tax Rate | 17.8% | -40.1% |
Financial Health
| Metric | JVA | MED |
|---|---|---|
| Current Ratio | 4.14x | 4.82x |
| Quick Ratio | 1.75x | 4.32x |
| D/E Ratio | 0.30x | 0.33x |
| Financial Leverage | 1.30x | 1.33x |
| Interest Coverage | 58.1x | 585.2x |
| Working Capital | $26M | $160M |
Cash Flow
| Metric | JVA | MED |
|---|---|---|
| Operating Cash Flow | $8M | -$30K |
| Free Cash Flow | $8M | -$4M |
| Capital Spending | -$200K | -$4M |
| OCF Growth YoY | – | -100.4% |
| FCF Growth YoY | – | -698.9% |
| FCF/Sales | 6.7% | -1.3% |
| CapEx/Sales | 0.2% | 1.3% |
Operational Efficiency
| Metric | JVA | MED |
|---|---|---|
| Asset Turnover | 2.95x | 1.25x |
| Receivables Turnover | 13.2x | – |
| Inventory Turnover | 5.8x | 4.3x |
| Fixed Assets Turnover | 37.1x | 22.6x |
| Days Sales Outstanding | 28 days | – |
| Days Inventory | 63 days | 84 days |
| Payables Period | 16 days | – |
| Cash Conversion Cycle | 75 days | – |
Income Statement
| Metric | JVA | MED |
|---|---|---|
| Total Revenue | $118M | $300M |
| Operating Income | $7M | -$35M |
| Net Income | $6M | -$41M |
| SG&A Expense | $16M | $242M |
| Cost of Goods Sold | $113M | $92M |
Dividend & Shareholder Information
| Metric | JVA | MED |
|---|---|---|
| Dividends Per Share | – | $0.07 |
| Shares Outstanding | 6M | 11M |
| Net Income Growth | 381.6% | -16639.3% |
| EPS Growth | 1925.0% | – |
JVA vs MED: stock comparison and AI forecast
Which is bigger, JVA or MED?
MED is 5.2 times larger than JVA by market capitalization ($142M against $28M).
Which stock performed better over the last six months, JVA or MED?
Over the last six months JVA returned +13.1% and MED +0.3%.
Which one does Intratio's AI model rank higher, JVA or MED?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.